Skip to Content
Merck
CN

739723

Glycocholic-2,2,4,4-d4 acid

98 atom % D, 98% (CP)

Synonym(s):

3α,7α,12α-Trihydroxy-5β-cholan-24-oic-2,2,4,4-d4 acid N-(carboxymethyl)amide, N-(3α,7α,12α-Trihydroxy-24-oxocholan-24-yl)-glycine-2,2,4,4-d4, Cholylglycine-2,2,4,4-d4

Sign In to View Organizational & Contract Pricing.

About This Item

Empirical Formula (Hill Notation):
C26D4H39NO6
CAS Number:
Molecular Weight:
469.65
UNSPSC Code:
12352111
PubChem Substance ID:
MDL number:
Isotopic purity:
98 atom % D
Assay:
98% (CP)
Mass shift:
M+4
Form:
powder


isotopic purity

98 atom % D

assay

98% (CP)

form

powder

technique(s)

mass spectrometry (MS): suitable

mp

165-168 °C (lit.)

mass shift

M+4

SMILES string

[H][C@@]12[C@]([C@](CC([2H])([2H])[C@@H](O)C3([2H])[2H])(C)[C@]3([H])C[C@H]2O)([H])C[C@H](O)[C@@]4(C)[C@@]1([H])CC[C@]4([H])[C@]([H])(C)CCC(NCC(O)=O)=O

InChI

1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1/i8D2,10D2

InChI key

RFDAIACWWDREDC-WZQUIQSLSA-N

Packaging

This product may be available from bulk stock and can be packaged on demand. For information on pricing, availability and packaging, please contact Stable Isotopes Customer Service.


pictograms

Environment

hcodes

Hazard Classifications

Aquatic Chronic 2

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Diana M Shih et al.
Journal of lipid research, 56(1), 22-37 (2014-11-08)
We performed silencing and overexpression studies of flavin containing monooxygenase (FMO) 3 in hyperlipidemic mouse models to examine its effects on trimethylamine N-oxide (TMAO) levels and atherosclerosis. Knockdown of hepatic FMO3 in LDL receptor knockout mice using an antisense oligonucleotide